Application of new bone repair materials in Department of Neurosurgery

A multicenter, randomized, single-blind, parallel controlled trial for the safety and efficacy of collagen-based bone repair materials be used for repairing bone defects in neurosurgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800018667

Enrollment

Unknown

Registered

2018-10-02

Start date

2018-11-01

Completion date

Unknown

Last updated

2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone defect

Interventions

1:Bone repair by collagen-based bone repair materials

2:Bone repair by Allogeneic bone or iliac artificial bone repair material

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-70 years male and female; 2. Patients with bone defects due to various causes; 3. Informed consent was obtained, and the informed consent was signed by the volunteers.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled severe diabetes. Uncontrolled severe hypertension patients with abnormal coagulation function; 2. There are serious heart disease, heart failure, history of myocardial infarction, systemic infection; 3. Patients with chronic kidney disease and renal insufficiency; 4. All kinds of acute and chronic liver diseases accompanied by severe liver dysfunction; 5. Specific allergy; 6. Pregnant women; 7. Patients who did not meet the inclusion criteria; 8. Taking part in other clinical trials within 3 months; 9. With other serious diseases that are unsuitable for inclusion.

Design outcomes

Primary

Measure	Time frame
CT value;	—

Countries

China

Contacts

Public ContactWang Yi

Tianjin Medical University General Hospital

sinuosiwo@sina.com+86 13920881956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026